Back to Agenda
Session 2 Track 3: Redefining the Impact of Field Medical: Elevate from Operational KPIs to Impact
Session Chair(s)
Mitra Sadeghi, PharmD
Sr. Director, Medical Affairs
Genentech, United States
For too long the success of Field Medical organization has been quantified by activity-based-metrics—number of interactions, frequency of visits, and resources delivered. While Key Performance Indicators (KPIs) provide a measure of effort, they fall short of capturing the profound strategic value that Medical Science Liaisons and their teams deliver. The true impact lies in the quality of scientific exchange, the strength of trusted partnerships, the generation of actionable insights, and the ultimate impact on clinical practice and patient outcomes. This session will be a forum for sharing innovative methodologies and forward-thinking strategies that move beyond counting activities and start measuring impact. We seek to build a new lexicon for value that reflects the integral role of Field Medical in the healthcare ecosystem.
Learning Objective : - Identify the importance of the value of velocity of insights
- Discuss measurements of scientific partnership strength
- Describe and demonstrate Internal and cross functional value
Speaker(s)
Speaker
Risa Reuscher
Genentech, United States
US Medical Regional Therapeutic Area Lead – South/Southeast
Speaker
Nicole Griswold, PharmD
Novartis, United States
Executive Medical Director, Head of Allergy/Immunology US Medical Affairs
Have an account?